文献速递冠心病外科

孤立性冠脉搭桥同期外科消融房颤的安全性与远期生存

Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

基于波兰KROK注册研究2006—2018年7879例合并房颤的孤立性CABG患者,346例(4.39%)同期行外科消融。经1:3倾向匹配后,消融组30天死亡风险比0.37(95%CI 0.15-0.91,P=0.032)、多器官衰竭风险比0.29(95%CI 0.10-0.94,P=0.029),远期总生存改善33%(HR 0.67,95%CI 0.49-0.90,P=0.008)。

要点

  • 孤立性CABG合并房颤者中仅4.39%同期接受外科消融。
  • 匹配后消融与30天死亡和多器官衰竭风险显著降低相关。
  • 消融与远期总生存显著改善相关,低危老年患者获益更明显。

核心结论

  • 孤立性CABG同期外科消融房颤是安全的,并与远期生存显著改善相关。

研究设计与样本

  • 基于波兰KROK国家心脏手术注册研究,纳入2006—2018年37个中心7879例合并房颤的孤立性CABG患者。
  • 平均随访4.7±3.5年,中位(四分位距)4.3(1.7-7.4)年,采用倾向评分匹配和Cox比例风险模型比较消融与单纯CABG。

主要发现

  • 346例(4.39%)接受外科消融,该组患者显著更年轻(66.4±7.5 vs 69.2±8.2,P<0.001),基线手术风险EuroSCORE差异无统计学意义(2.11 vs 2.50,P=0.088)。
  • 1:3倾向匹配后(消融306例 vs 单纯CABG 918例),消融与较低的30天死亡风险相关(风险比0.37,95%CI 0.15-0.91,P=0.032)。
  • 消融与较低的多器官衰竭风险相关(风险比0.29,95%CI 0.10-0.94,P=0.029)。
  • 远期消融与总生存显著改善33%相关(HR 0.67,95%CI 0.49-0.90,P=0.008)。
  • 获益在亚组中持续存在,在年龄>70岁(P=0.020)、择期(P=0.011)、三支病变(P=0.036)、脑血管意外史(P=0.018)、左室射血分数>50%(P=0.017)、无心力衰竭症状(NYHA,P=0.001)及体外循环CABG(P<0.001)的低危老年患者中更明显。

临床怎么用

  • 对合并房颤的孤立性CABG患者,可考虑同期行外科消融以改善远期生存。
  • 低危老年(>70岁)、择期、三支病变、左室功能保留及体外循环CABG患者可能获益更明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our goal was to evaluate early sequelae and long-term survival in patients undergoing isolated coronary artery bypass grafting (CABG) with concomitant surgical ablation for atrial fibrillation (AF). METHODS: Procedural data from KROK (Polish National Registry of Cardiac Surgery Procedures) were collected. A total of 7879 patients with underlying AF underwent isolated CABG between 2006 and 2018 in 37 reference centres across Poland. The mean follow-up was 4.7 ± 3.5 years [median (interquartile range) 4.3 (1.7-7.4)]. Propensity score matching and Cox proportional hazards models were used to compare isolated CABG + ablation with isolated CABG. RESULTS: Of the included patients, 346 (4.39%) underwent surgical ablation. Patients in this group were significantly younger (66.4 ± 7.5 vs 69.2 ± 8.2; P < 0.001) but had a non-significant, different baseline surgical risk (EuroSCORE: 2.11 vs 2.50; P = 0.088). After a rigorous 1:3 propensity matching (LOGIT model: 306 cases of isolated CABG + ablation vs 918 of isolated CABG alone), surgical ablation was associated with a lower 30-day risk of death [risk ratio 0.37, 95% confidence interval (CI) 0.15-0.91; P = 0.032] and multiorgan failure (risk ratio 0.29, 95% CI 0.10-0.94; P = 0.029). In the long term, surgical ablation was associated with a significant 33% improved overall survival rate: hazard ratio 0.67, 95% CI 0.49-0.90; P = 0.008. The benefit of ablation was sustained in the subgroups but was most pronounced in lower risk older patients (age >70 years, P = 0.020; elective status, P = 0.011) with 3-vessel disease (P = 0.036), history of a cerebrovascular accident (P = 0.018) and preserved left ventricular function [left ventricular ejection fraction >50%; P = 0.017; no signs of heart failure (per New York Heart Association functional class); P = 0.001] and those undergoing on-pump CABG (P < 0.001). CONCLUSION: Surgical ablation for AF in patients undergoing isolated CABG is safe and associated with significantly improved long-term survival.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Suwalski P, Kowalewski M, Jasiński M, et al. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery. Eur J Cardiothorac Surg. 2020. PMID: 31665277. doi:10.1093/ejcts/ezz298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。